These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 13185234)

  • 1. A FIELD investigation of PTAP (purified toxoid, aluminium-phosphate-precipitated).
    Mon Bull Minist Health Public Health Lab Serv; 1954 Jul; 13():127-41. PubMed ID: 13185234
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative immunizing efficiency of diphtheria toxoid preparations.
    GREENBERG L
    Bull World Health Organ; 1955; 12(5):751-60. PubMed ID: 14379009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aluminium phosphate and aluminium hydroxide on the antigenicity of purified diphtheria toxoid.
    HALONEN P; JANNES L
    Ann Med Exp Biol Fenn; 1955; 33(1-2):5-11. PubMed ID: 14388313
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of diphtheria toxoid aluminium-phosphate-precipitated; to determine optional aluminium-phosphate content.
    BOUSFIELD G
    Lancet; 1947 Mar; 1(6443-6445):286-8. PubMed ID: 20287148
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON THE SURFACE STRUCTURE AND CHEMICAL COMPOSITION OF DIPHTHERIA TOXIN AND TOXOID. I. BINDING OF COPPER IONS BY PURIFIED DIPHTHERIA TOXIN AND TOXOID].
    ISKIERKO J
    Med Dosw Mikrobiol; 1963; 15():199-206. PubMed ID: 14062752
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium.
    Netterlid E; Bruze M; Hindsén M; Isaksson M; Olin P
    Vaccine; 2004 Sep; 22(27-28):3698-706. PubMed ID: 15315849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results with diphtheria phosphate toxoid].
    TASMAN A; LEBRET JD
    Ned Tijdschr Geneeskd; 1955 Apr; 99(14):1030-7. PubMed ID: 14383827
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the absorption by rectal route of purified diphtheria toxoid].
    POSTERARO G; PRATO C; SOPRANO D
    Riv Ist Sieroter Ital; 1954; 29(6):554-8. PubMed ID: 14358385
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.
    Jackson LA; Yu O; Nelson J; Belongia EA; Hambidge SJ; Baxter R; Naleway A; Nordin J; Baggs J; Iskander J
    Vaccine; 2009 Aug; 27(36):4912-6. PubMed ID: 19567245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory research on various types of Yugoslavmade APT and PTAP diphtheria vaccines].
    IKIC D
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):264-9. PubMed ID: 13405410
    [No Abstract]   [Full Text] [Related]  

  • 11. [Active immunization of infants against diphtheria with anatoxin absorbed on hydroxide and phosphate of aluminium; comparative responses to the two vaccines].
    JEMMA A
    Minerva Nipiol; 1955; 5(2):41-4. PubMed ID: 14393868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preparation of diphtheria antitoxin by immunization of horses with purified toxoid].
    RELYVELD EH; GIRARD O; CORVAZIER R; RAYNAUD M
    Ann Inst Pasteur (Paris); 1957 May; 92(5):631-41. PubMed ID: 13425115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preparation of anti-diphtheria sera with high flocculating titers and weak neutralizing activity, by the immunization of Schick-positive horses with a highly-purified toxoid].
    RAYNAUD M; RELYVELD EH; GIRARD O; CORVAZIER R
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):129-39. PubMed ID: 13627578
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel.
    Valinsky L; Simhoni S; Bassal R; Agmon V; Yishai R; Green MS; Cohen D
    Clin Microbiol Infect; 2006 Oct; 12(10):968-73. PubMed ID: 16961632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques.
    Metz B; Jiskoot W; Mekkes D; Kingma R; Hennink WE; Crommelin DJ; Kersten GF
    Vaccine; 2007 Sep; 25(39-40):6863-71. PubMed ID: 17707558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid.
    Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M
    Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.
    Danilova E; Shiryayev A; Skogen V; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Feb; 23(12):1446-50. PubMed ID: 15670879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine.
    Carlin G; Viitanen E
    Vaccine; 2005 May; 23(28):3709-15. PubMed ID: 15882532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.